(Q30241943)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27767036%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

review article

1 reference

title

Sphingolipids and phospholipids in insulin resistance and related metabolic disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27767036%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27767036%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Scott A Summers

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27767036%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

author name string

Peter J Meikle

series ordinal

1

1 reference

12 June 2017

Scott A Summers

series ordinal

2

1 reference

12 June 2017

publication date

21 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27767036%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Endocrinology

26 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27767036%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27767036%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27767036%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

page(s)

79-91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27767036%20AND%20SRC:MED&resulttype=core&format=json

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

26 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Selective versus total insulin resistance: a pathogenic paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Optimizing the lipidomics workflow for clinical studies--practical considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Applications of mass spectrometry for cellular lipid analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasma lipid profiling in a large population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasma lipidomics discloses metabolic syndrome with a specific HDL phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Lipidomic analysis of plasma, erythrocytes and lipoprotein fractions of cardiovascular disease patients using UHPLC/MS, MALDI-MS and multivariate data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

High density lipoprotein efficiently accepts surface but not internal oxidised lipids from oxidised low density lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Glycerolipid metabolism and signaling in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Enzymes of triacylglycerol synthesis and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Phosphatidylcholine biosynthesis and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Phospholipid biosynthesis in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Disruption of the phosphatidylserine decarboxylase gene in mice causes embryonic lethality and mitochondrial defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

The CDP-Ethanolamine Pathway Regulates Skeletal Muscle Diacylglycerol Content and Mitochondrial Biogenesis without Altering Insulin Sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Animal models of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Finding the balance: the role of S-adenosylmethionine and phosphatidylcholine metabolism in development of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasmalogens the neglected regulatory and scavenging lipid species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Purification, identification, and cloning of lysoplasmalogenase, the enzyme that catalyzes hydrolysis of the vinyl ether bond of lysoplasmalogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasma lipidomic analysis of stable and unstable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

The effect of shark liver oil on the tumor infiltrating lymphocytes and cytokine pattern in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

GM3 ganglioside and phosphatidylethanolamine-containing lipids are adipose tissue markers of insulin resistance in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Ceramide is a cardiotoxin in lipotoxic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Deoxysphingoid bases as plasma markers in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Deoxysphingolipids, novel biomarkers for type 2 diabetes, are cytotoxic for insulin-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Ceramides - Lipotoxic Inducers of Metabolic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Ceramides and glucosylceramides are independent antagonists of insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasma ceramides are elevated in female children and adolescents with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Reduced skeletal muscle oxidative capacity and elevated ceramide but not diacylglycerol content in severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Skeletal muscle ceramide species in men with abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Ceramide content is increased in skeletal muscle from obese insulin-resistant humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

CrossTalk opposing view: Intramyocellular ceramide accumulation does not modulate insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

CrossTalk proposal: Intramyocellular ceramide accumulation does modulate insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

C16:0-ceramide signals insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

HDL-sphingomyelin reduction after weight loss by an energy-restricted diet is associated with the improvement of lipid profile, blood pressure, and decrease of insulin resistance in overweight/obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Reducing plasma membrane sphingomyelin increases insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/- mice and rabbits fed a high-fat and -cholesterol diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Insulin resistance as a membrane microdomain disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Ganglioside GM3 participates in the pathological conditions of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Enhanced insulin sensitivity in mice lacking ganglioside GM3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Mitochondrial dysfunction indirectly elevates ROS production by the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Role of S-adenosyl-L-methionine in liver health and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Dietary ether lipid incorporation into tissue plasmalogens of humans and rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Modulation of endothelial permeability by 1-O-alkylglycerols

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

An update on the therapeutic role of alkylglycerols

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

A lipidomics analysis of the relationship between dietary fatty acid composition and insulin sensitivity in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

A Healthy Nordic Diet Alters the Plasma Lipidomic Profile in Adults with Features of Metabolic Syndrome in a Multicenter Randomized Dietary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Exercise and Weight Loss Improve Muscle Mitochondrial Respiration, Lipid Partitioning, and Insulin Sensitivity After Gastric Bypass Surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Ceramides as modulators of cellular and whole-body metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

A ceramide-centric view of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Simultaneous determination of nucleosides, myriocin, and carbohydrates in Cordyceps by HPLC coupled with diode array detection and evaporative light scattering detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Determination of myriocin in natural and cultured Cordyceps cicadae using 9-fluorenylmethyl chloroformate derivatization and high-performance liquid chromatography with UV-detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

The mechanisms of Fenretinide-mediated anti-cancer activity and prevention of obesity and type-2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Dihydroceramides: From Bit Players to Lead Actors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Clinical trials with retinoids for breast cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Glycosphingolipids and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Developing novel chemical entities for the treatment of lysosomal storage disorders: an academic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Myeloid cell-specific serine palmitoyltransferase subunit 2 haploinsufficiency reduces murine atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Inhibition of ceramide synthesis reverses endothelial dysfunction and atherosclerosis in streptozotocin-induced diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

1-O-alkylglycerols reduce the stimulating effects of bFGF on endothelial cell proliferation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.169

The design and clinical development of inhibitors of glycosphingolipid synthesis: will invention be the mother of necessity?

31 March 2020

1 reference

12 December 2020

Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease

1 reference

12 December 2020

Oral administration of alkylglycerols differentially modulates high-fat diet-induced obesity and insulin resistance in mice

1 reference

12 December 2020

Studies on the antidiabetic activities of Cordyceps militaris extract in diet-streptozotocin-induced diabetic Sprague-Dawley rats

1 reference

12 December 2020

Ceramide dissociates 3'-phosphoinositide production from pleckstrin homology domain translocation

1 reference

12 December 2020

Hypoglycemic Activity through a Novel Combination of Fruiting Body and Mycelia of Cordyceps militaris in High-Fat Diet-Induced Type 2 Diabetes Mellitus Mice

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2016.169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27767036%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference